These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 8325337)

  • 21. Evidence that cutaneous antigen-presenting cells migrate to regional lymph nodes during contact sensitization.
    Kripke ML; Munn CG; Jeevan A; Tang JM; Bucana C
    J Immunol; 1990 Nov; 145(9):2833-8. PubMed ID: 2212665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lymph node resident rather than skin-derived dendritic cells initiate specific T cell responses after Leishmania major infection.
    Iezzi G; Fröhlich A; Ernst B; Ampenberger F; Saeland S; Glaichenhaus N; Kopf M
    J Immunol; 2006 Jul; 177(2):1250-6. PubMed ID: 16818784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fresh and cultured Langerhans cells display differential capacities to activate hapten-specific T cells.
    Dai R; Grammer SF; Streilein JW
    J Immunol; 1993 Jan; 150(1):59-66. PubMed ID: 8417131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exacerbation of experimental murine cutaneous leishmaniasis with CD4+ Leishmania major-specific T cell lines or clones which secrete interferon-gamma and mediate parasite-specific delayed-type hypersensitivity.
    Titus RG; Müller I; Kimsey P; Cerny A; Behin R; Zinkernagel RM; Louis JA
    Eur J Immunol; 1991 Mar; 21(3):559-67. PubMed ID: 1672641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro evidence that Langerhans cells can adopt two functionally distinct forms capable of antigen presentation to T lymphocytes.
    Streilein JW; Grammer SF
    J Immunol; 1989 Dec; 143(12):3925-33. PubMed ID: 2592763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular cloning of a novel protein antigen of Leishmania major that elicits a potent immune response in experimental murine leishmaniasis.
    Webb JR; Kaufmann D; Campos-Neto A; Reed SG
    J Immunol; 1996 Dec; 157(11):5034-41. PubMed ID: 8943412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mature DC from skin and skin-draining LN retain the ability to acquire and efficiently present targeted antigen.
    Henri S; Siret C; Machy P; Kissenpfennig A; Malissen B; Leserman L
    Eur J Immunol; 2007 May; 37(5):1184-93. PubMed ID: 17407099
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A role for gamma delta + T cells during experimental infection of mice with Leishmania major.
    Rosat JP; MacDonald HR; Louis JA
    J Immunol; 1993 Jan; 150(2):550-5. PubMed ID: 8419488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Presentation of the protective parasite antigen LACK by Leishmania-infected macrophages.
    Prina E; Lang T; Glaichenhaus N; Antoine JC
    J Immunol; 1996 Jun; 156(11):4318-27. PubMed ID: 8666803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunization of susceptible hosts with a soluble antigen fraction from Leishmania major leads to aggravation of murine leishmaniasis mediated by CD4+ T cells.
    Bogdan C; Schröppel K; Lohoff M; Röllinghoff M; Solbach W
    Eur J Immunol; 1990 Dec; 20(12):2533-40. PubMed ID: 1980108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T cell priming in vivo: a major role for B cells in presenting antigen to T cells in lymph nodes.
    Ron Y; Sprent J
    J Immunol; 1987 May; 138(9):2848-56. PubMed ID: 2952725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activated T cells induce expression of E-selectin in vitro and in an antigen-dependent manner in vivo.
    Sunderkötter C; Steinbrink K; Henseleit U; Bosse R; Schwarz A; Vestweber D; Sorg C
    Eur J Immunol; 1996 Jul; 26(7):1571-9. PubMed ID: 8766563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of E-cadherin by murine dendritic cells: E-cadherin as a dendritic cell differentiation antigen characteristic of epidermal Langerhans cells and related cells.
    Borkowski TA; Van Dyke BJ; Schwarzenberger K; McFarland VW; Farr AG; Udey MC
    Eur J Immunol; 1994 Nov; 24(11):2767-74. PubMed ID: 7957569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cutaneous immune system].
    Schmitt D
    C R Seances Soc Biol Fil; 1994; 188(3):207-21. PubMed ID: 7834504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccination against cutaneous leishmaniasis in a murine model. I. Induction of protective immunity with a soluble extract of promastigotes.
    Scott P; Pearce E; Natovitz P; Sher A
    J Immunol; 1987 Jul; 139(1):221-7. PubMed ID: 3495599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T-cell responses to immunodominant LACK antigen do not play a critical role in determining susceptibility of BALB/c mice to Leishmania mexicana.
    Torrentera FA; Glaichenhaus N; Laman JD; Carlier Y
    Infect Immun; 2001 Jan; 69(1):617-21. PubMed ID: 11119565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of antigen-presenting cells in the regulation of delayed-type hypersensitivity. II. Epidermal Langerhans' cells and peritoneal exudate macrophages.
    Morikawa Y; Furotani M; Matsuura N; Kakudo K
    Cell Immunol; 1993 Nov; 152(1):200-10. PubMed ID: 8242760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antigen processing: cultured lymph-borne dendritic cells can process and present native protein antigens.
    Liu LM; MacPherson GG
    Immunology; 1995 Feb; 84(2):241-6. PubMed ID: 7751000
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endothelial nitric oxide synthase limits the inflammatory response in mouse cutaneous leishmaniasis.
    Fritzsche C; Schleicher U; Bogdan C
    Immunobiology; 2010; 215(9-10):826-32. PubMed ID: 20576313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Experimental cutaneous leishmaniasis: Langerhans cells internalize Leishmania major and induce an antigen-specific T-cell response.
    Moll H
    Adv Exp Med Biol; 1993; 329():587-92. PubMed ID: 8379429
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.